Brian Joshua Linde, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Linde’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C186770 · Current
Licensed to practise in California · since 2023 · expires 2027-06-30 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Preventive Medicine - Occupational Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 73.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 16 Part D prescriptions in 2016. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2017 | 26 | 13 | None | None | $719 |
| 2016 | 16 | None | 0% (0) | None | $1,736 |
| 2015 | 111 | 50 | None | 28% | $13,933 |
| 2014 | 210 | 59 | 9% (18) | None | $29,136 |
| 2013 | 106 | 36 | None | None | $3,638 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$250 in 2025
| 2025 | 1 | 1 | $250 | $250 |
| 2024 | 1 | 1 | $810 | $810 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | None | $250 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Consulting · 2025-02-19 | None | $250 |
See earlier years (2024)
2024: $810
| Merck Sharp & Dohme | None | $810 | 1 payment
|
Professional record
- NPI
- 1871868174
- Licence
- CA C186770, CT 53864California C186770: Current · expires 2027-06-30
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 2083P0500X (2083P0500X); Federal specialty code 2083X0100X (2083X0100X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-03-20
- NPI last updated
- 2024-04-19
- NPI record certified
- 2024-04-19
This is when the NPI record was last certified, not a medical board exam.